P

Inventor

IVETAC ANTHONY

US11 patents
⚠️ This page may combine multiple inventors who share the name “IVETAC ANTHONY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MIRATI THERAPEUTICS INC

6 patents
US12421253B2Sep 23, 2025

Tetrahydropyridopyrimidine pan-KRas inhibitors

MIRATI THERAPEUTICS INC1 citations63
US12304915B2May 20, 2025

SOS1 inhibitors

MIRATI THERAPEUTICS INC0 citations61
US11999753B2Jun 4, 2024

Tetrahydropyridopyrimidine pan-KRas inhibitors

MIRATI THERAPEUTICS INC1 citations61
US11702418B2Jul 18, 2023

SOS1 inhibitors

MIRATI THERAPEUTICS INC0 citations61
US11492351B2Nov 8, 2022

MTA-cooperative PRMT5 inhibitors

MIRATI THERAPEUTICS INC0 citations61
US11479551B2Oct 25, 2022

MTA-cooperative PRMT5 inhibitors

MIRATI THERAPEUTICS INC1 citations61

TAKEDA PHARMACEUTICALS CO

3 patents
US9708296B2Jul 18, 2017

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

TAKEDA PHARMACEUTICALS CO2 citations71
US10407409B2Sep 10, 2019

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

TAKEDA PHARMACEUTICALS CO0 citations51
US9944626B2Apr 17, 2018

6-(5-hydroxy-1H-pyrazol-1-YL)nicotinamide inhibitors of PHD

TAKEDA PHARMACEUTICALS CO0 citations51

TAKEDA PHARMACEUTICAL

2 patents
US9040522B2May 26, 2015

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

TAKEDA PHARMACEUTICAL7 citations82
US9345713B2May 24, 2016

6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD

TAKEDA PHARMACEUTICAL3 citations71